Journal of Physiology & Pathology in Korean Medicine (동의생리병리학회지)

The Physiological Society of Korean Medicine and The Society of Pathology in Korean Medicine (대한동의생리학회·한의병리학회)
권호 표지

Immunohistochemical Study of Yanggyuksanhwa-tang on Focal Cerebral Ischemia of Diabetic Rats

당뇨흰쥐의 국소뇌허혈에 대한 양격산화탕(凉膈散火湯)의 면역조직화학적 연구

  • Boo, Il-Gwon (Department of Anatomy-Pointlogy, College of Oriental Medicine, Kyungwon University) ;
  • Kim, Youn-Sub (Department of Anatomy-Pointlogy, College of Oriental Medicine, Kyungwon University)
  • 부일권 (경원대학교 한의과대학 해부경혈학교실) ;
  • 김연섭 (경원대학교 한의과대학 해부경혈학교실)
  • Published : 2007.06.25
Download PDF
⟨ Previous Next ⟩

Abstract

This study evaluated neuroprotective effects of Yanggyuksanhwa-tang (YST), which have been known to be efficacy in the treatment of the stroke and diabetes. on focal cerebral ischemia of diabetic rats. On primary experiment, diabetic condition in rats was induced by streptozotocin injection, then, focal cerebral ischemia was induced by the middle cerebral artery occlusion (MCAO) under the diabetic condition. Then neuroprotective effect of YST was observed with changes of infarct size and volume, expressions of c-Fos, Bax, and hypoxia inducible factor (HIF)-1${\alpha}$ in the brain tissues by using 2% 2,3,5-triphenyltetrazolium chloride (TTC) staining and immunohistochemistry. YST treatment showed a significant decrease of infarct size and volume induced by MCAO in diabetic rats. YST treatment showed a significant decrease of c-Fos and Bax positive neurons in cortex penumbra. YST treatment showed a decrease of HIF-l${\alpha}$ positive neurons in cortex penumbra, but it was not significant statistically. These results suggest that YST has effects on neuroprotection against cerebral infarct under diabetic condition. And it is supposed that neuroprotective effect of YST reveals by anti-apoptosis mechanism.

Keywords

References

  1. Vinik, A.I., Vinik, E. Prevention of the complications of diabetes. Am J Manag Care. 9: S63-80, 2003
  2. Candido, R., Srivastava, P., Cooper, M.E., Burrell, L.M. Diabetes mellitus: a cardiovascular disease. Curr Opin Investig Drugs. 4(9):1088-1094, 2003
  3. Piechowski-Jozwiak, B., Maulaz, A., Bogousslavsky, J. Secondary prevention of stroke with antiplatelet agents in patients with diabetes mellitus. Cerebrovasc Dis. 20: 15-23 https://doi.org/10.1159/000088233
  4. Bloomgarden, Z.T. Diabetic retinopathy and neuropathy. Diabetes Care. 28(4):963-970, 2005 https://doi.org/10.2337/diacare.28.4.963
  5. Kurukulasuriya, L.R., Govindarajan, G., Sowers, J. Stroke prevention in diabetes and obesity. Expert Rev Cardiovasc Ther. 4(4):487-502, 2006 https://doi.org/10.1586/14779072.4.4.487
  6. Goldstein, L.B., Adams, R., Alberts, M.J., Appel, L.J., Brass, L.M., Bushnell, C.D., Culebras, A., DeGraba, T.J., Gorelick, P.B., Guyton, J.R., Hart, R.G., Howard, G., Kelly-Hayes, M., Nixon, J.V., Sacco, R.L. American Heart Association; American Stroke Association Stroke Council. Primary prevention of ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council: cosponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Council; Clinical Cardiology Council; Nutrition, Physical Activity, and Metabolism Council; and the Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation. 113(24):e873-923, 2006 https://doi.org/10.1161/01.STR.0000223048.70103.F1
  7. Frizzell, J.P. Acute stroke: pathophysiology, diagnosis, and treatment. AACN Clin Issues. 16(4):421-440, 2005 https://doi.org/10.1097/00044067-200510000-00002
  8. Hankey, G.J. Potential new risk factors for ischemic stroke: what is their potential? Stroke. 37(8):2181-2188, 2006 https://doi.org/10.1161/01.STR.0000229883.72010.e4
  9. Britton, M., Rafols, J., Alousi, S., Dunbar, J.C. The effects of middle cerebral artery occlusion on central nervous system apoptotic events in normal and diabetic rats. Int J Exp Diabesity Res. 4(1):13-20, 2003 https://doi.org/10.1080/15438600303727
  10. Muranyi M, Fujioka M, He Q, Han A, Yong G, Csiszar K, Li PA. Diabetes activates cell death pathway after transient focal cerebral ischemia. Diabetes. 52(2):481-486, 2003 https://doi.org/10.2337/diabetes.52.2.481
  11. 李濟馬. 東醫壽世保元, 서울, 신일문화사, p 70, 1964
  12. 元持常. 東醫四象新編, 서울, 綜合醫苑社, pp 20-54, 66, 1974
  13. 송일병. 사상의학적 중풍관리의 임상적 연구. 사상의학회지 8(2):117-129, 1996
  14. 李泰浩. 東醫四象診療醫典, 서울, 杏林出版社, p 253, 1983
  15. 洪淳用, 李乙浩. 四象醫學原論, 서울, 杏林出版社, pp 274-301, 1985
  16. 배철환, 조기호, 이원철, 김영석, 배형섭, 이경섭, 구본홍. 폐쇄성 뇌졸중에 대한 임상적 연구. 경희한의대논문집. 10: 665-687, 1987
  17. 윤진구, 조기호, 김영석, 이경섭. 뇌졸중에 관한 임상통계적 연구. 대한한방내과학회지 10(1):25-38, 1989
  18. 김진성, 송일병. 凉膈散火湯의 효능에 관한 실험적 연구. 경희한의대논문집. 7: 273-285, 1984
  19. 이기주, 김경요. 십이미관중탕, 凉膈散火湯, 형방사백산이 백서의 혈압 및 국소 뇌혈류량에 미치는 영향. 한국전통의학지 9(2):259-268, 1999
  20. 홍성범, 홍순용. 소양인에 응용되는 凉膈散火湯이 백서의 당뇨병에 미치는 영향. 사상의학회지 3(1):201-217, 1991
  21. 최병일, 고병희, 송일병. 소양인 凉膈散火湯과 인동등지골피탕 및 숙지황고삼탕이 Allxan 투여 고혈당 백서에 미치는 영향. 경희한의대논문집. 15: 113-133, 1992
  22. Zea Longa, E.L., Weinstein, P.R., Carlson, S., Cummins, R. Reversible middle cerebral artery occlusion without craniectomy in rats. stroke. 20: 84-91, 1989 https://doi.org/10.1161/01.STR.20.1.84
  23. Swanson, R.A., Morton, M.T., Tsao-Wu, G., Savalos, R.A., Davidson, C., Sharp, F.R. A semiautomated method for measuring brain infarct volume. J Cereb Blod Flow Metab. 10(2):290-293, 1990 https://doi.org/10.1038/jcbfm.1990.47
  24. 이동원, 이원철. 지주막하출혈에 의한 뇌기저동맥의 형태학적 변화에 미치는 凉膈散火湯의 효과. 대한한의학회지 20(2):146-156, 1999
  25. 이동원, 이원철. 지주막하출혈 후 뇌기저동맥벽에 존재하는 면역양성 신경섬유의 변화에 미치는 凉膈散火湯의 효과. 한의학연구소논문집 8(1):117-131, 1999
  26. Neumann-Haefelin, T., Wiessner, C., Vogel, P., Back, T., Hossmann, K.A. Differential expression of the immediate early genes c-fos, c-jun, junB, and NGFI-B in the rat brain following transient forebrain ischemia. J Cereb Blood Flow Metab. 14: 206-216, 1994 https://doi.org/10.1038/jcbfm.1994.27
  27. Onodera, H., Kogure, K., Ono, Y., Igarashi, K., Kiyota, Y., Nagaoka, A. Proto- oncogene c-fos is transiently induced in the rat cerebral cortex after forebrain ischemia. Neurosci Lett. 98: 101-104, 1989 https://doi.org/10.1016/0304-3940(89)90381-9
  28. Nicholson, D.W. Mechanisms of apoptotic control. Nature. 407: 810-816, 2000 https://doi.org/10.1038/35037747
  29. Gillardon, F., Wickert, H., Zimmermann, M. Up-regulation of Bax and down- regulation of Bcl-2 is associated with kainate-induced apoptosis in mouse brain. Neurosci Lett. 192: 85-88, 1995 https://doi.org/10.1016/0304-3940(95)11619-8
  30. Hara, A., Iwai, T., Niwa, M. Immunohistochemical detection of BAX and BCl-2 proteins in gerbil hippocampus following transient forebrain ischemia. Brain Res. 711: 249-253, 1996 https://doi.org/10.1016/0006-8993(95)01436-5
  31. Bergeron, M., Yu, A.Y., Solway, K.E., Semenza, G.L., Sharp, F.R. Induction of hypoxia-inducible factor-1 (HIF-1) and its target genes following focal ischemia in rat brain. Eur J Neurosci. 11: 4159-4170, 1999 https://doi.org/10.1046/j.1460-9568.1999.00845.x
  32. Brune, B., Brune, B., von Knethen, A., Sandau, K.B. Transcription factors p53 and HIF-1alpha as targets of nitric oxide. Cell Signal. 13(8):525-533, 2001 https://doi.org/10.1016/S0898-6568(01)00175-9
  33. Semenza, G.L. Hypoxia-inducible factor 1: oxygen homeostasis and disease pathophysiology. Trends Mol Med. 7(8):345-350, 2001 https://doi.org/10.1016/S1471-4914(01)02090-1
  34. Moritz, W., Meier, F., Stroka, D.M., Giuliani, M., Kugelmeier, P., Nett, P.C., Lehmann, R., Candinas, D., Gassmann, M., Weber, M. Apoptosis in hypoxic human pancreatic islets correlates with HIF-1alpha expression. FASEB J. 16(7):745-747, 2002 https://doi.org/10.1096/fj.01-0403fje
  35. Halterman, M.W., Federoff, H.J. HIF-1alpha and p53 promote hypoxia-induced delayed neuronal death in models of CNS ischemia. Exp Neurol. 159(1):65-72, 1999 https://doi.org/10.1006/exnr.1999.7160
  36. Piret, J.P., Mottet, D., Raes, M., Michiels, C. Is HIF-1alpha a pro- or an anti-apoptotic protein? Biochem Pharmacol. 64(5-6):889-892, 2002 https://doi.org/10.1016/S0006-2952(02)01155-3